… Anti-PC autoantibodies have been … cardiovascular outcomes in patients with acute coronary
syndromes (ACS). We measured anti-PC levels within 7 days of an ACS in 3,356 patients …

… ) autoantibodies against PC add prognostic information in acute coronary syndromes (ACS). …
Immunoglobulin-M (IgM) autoantibodies against phosphorylcholine (anti-PC) are a putative …

… Low concentrations of IgM-phosphorylcholine autoantibodies (IgM-anti-PC) have …
cardiovascular disease (CVD) events and total mortality in patients suffering from an acute coronary …

… CV disease risk prediction varies from 17 to 29 U mL −1 according to published reports [15,
16], and because no data are currently available for NSTEMI prediction with this autoantibody…

… We hypothesized that the association between IgM anti-PC and the risk of CV outcome is
different in the presence of CV risk factors. We therefore further performed analyses within the …

… and coronary occlusion is the leading underlying cause of myocardial infarction and sudden
cardiac … Autoantibodies directed towards a variety of oxidation-specific epitopes or self—…

Objective Phosphorylcholine (PC) is one important epitope on oxidized low-density
lipoprotein that may play an important role by contributing to the atherogenicity of oxidized low-…

… autoantibody (highest vs. lowest quartiles of autoantibody titer) on cardiovascular outcomes.
… the association between anti phosphorylcholine autoantibodies (anti-PC)- and CVD-related …

… could be related to the complexity of the LDL-oxidation process where antigens exposed
could vary to some extent, and there may also be differences in methods used for antibody …

Atherosclerosis is an inflammatory condition characterised by an abundance of activated
immunocompetent cells in plaques which cause cardiovascular disease (CVD) when they …